vancomycin has been researched along with hr 810 in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.88) | 18.7374 |
1990's | 12 (70.59) | 18.2507 |
2000's | 4 (23.53) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishikawa, H; Matsumoto, M; Shitsuta, T; Tsubouchi, H; Tsuji, K; Yasumura, K | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Amalfitano, G; Canepari, P; Fontana, R; Ligozzi, M; Piacentini, E | 1 |
Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
Baltch, AL; Ritz, WJ; Smith, RP; Valdes, JM | 1 |
Chandrasekar, PH; Levine, DP; Price, S | 1 |
Harauchi, T; Hirata, M; Itoh, F; Mizushima, Y; Sato, K | 1 |
Ehrett, S; Friedland, IR; Hickey, S; McCracken, GH; Olsen, K; Paris, M | 1 |
Hasegawa, H; Kanai, A; Otoguro, K; Shimizu, K | 1 |
Appelbaum, PC; Bajaksouzian, S; Jacobs, MR; Visalli, MA | 1 |
Bergeret, M; Raymond, J; Vedel, G | 2 |
Allende, H; Almirante, B; Capdevila, JA; Crespo, E; Gavaldà , J; Laguarda, M; Otero, J; Pahissa, A; Pigrau, C; Ruiz, I | 1 |
Bergeret, M; Raymond, J | 1 |
Aubert, G; Carricajo, A; Vermesch, R | 1 |
Andrieu, P; Archambaud, M; Bonnet, E; Chabanon, G; Chaminade, B; Conil, JM; Cougot, P; Decun, JF; Georges, B; Houin, G; Roche, C; Saivin, S; Samii, K; Virenque, C | 1 |
Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
1 trial(s) available for vancomycin and hr 810
Article | Year |
---|---|
[Importance of a cefpirome-vancomycin combination on bactericidal kinetics in severe MRSA infections in intensive care].
Topics: Adult; Aged; Bacteremia; Cefpirome; Cephalosporins; Critical Care; Drug Therapy, Combination; Female; Humans; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2002 |
16 other study(ies) available for vancomycin and hr 810
Article | Year |
---|---|
Synthesis and biological evaluation of a series of new parenteral optically active 3-[[(N-alkylpyridinium-4'-yl)thio]methyl]-2-oxaisocephems.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Stereoisomerism | 1995 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activity of cefpirome (HR 810) against enterococci and staphylococci.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Enterococcus faecalis; Microbial Sensitivity Tests; Species Specificity; Staphylococcus; Vancomycin | 1992 |
The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
Topics: Cefoperazone; Cefpirome; Cephalosporins; Drug Therapy, Combination; Enterococcus; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1992 |
In-vitro susceptibilities of gram-positive bacteria to cefpirome, vancomycin, isepamicin and gentamicin, singly and in combination.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Therapy, Combination; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests; Vancomycin | 1990 |
In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.
Topics: Ampicillin; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Enterococcus faecalis; Glycopeptides; In Vitro Techniques; Microbial Sensitivity Tests; Piperacillin; Streptococcus; Teicoplanin; Vancomycin | 1985 |
[Modification of vancomycin nephrotoxicity by other antibiotics in rats].
Topics: Animals; Cefpirome; Cephalosporins; Drug Therapy, Combination; Kidney; Male; Moxalactam; Rats; Rats, Sprague-Dawley; Vancomycin | 1995 |
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Rifampin; Thienamycins; Vancomycin | 1993 |
[Combination effect of vancomycin and cefpirome against methicillin-resistant Staphylococcus aureus in vitro--antimicrobial activities in postantibiotic phase].
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Synergism; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1996 |
Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Teicoplanin; Time Factors; Vancomycin | 1996 |
In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Coagulase; Drug Therapy, Combination; Kinetics; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin | 1996 |
Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Culture Media; Half-Life; Lung; Male; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Rats; Rats, Wistar; Streptococcus pneumoniae; Vancomycin | 1997 |
In vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative Staphylococcus.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Coagulase; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin | 1998 |
In-vitro bactericidal activity of cefpirome and cefamandole in combination with glycopeptides against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefamandole; Cefpirome; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Serum Bactericidal Test; Staphylococcus aureus; Teicoplanin; Vancomycin | 1999 |
In vitro activity of cefpirome and vancomycin in combination against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2001 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |